Switch to
More onapp

Lyka Labs Ltd

LYKALABS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹376 cr, stock is ranked 1,462
High RiskStock is 3.30x as volatile as Nifty
133.401.60 (+1.21%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹376 cr, stock is ranked 1,462
High RiskStock is 3.30x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
9.64
PB RatioPB Ratio
26.36
Dividend YieldDiv. Yield
Sector PESector PE
34.26
Sector PBSector PB
4.19
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lyka Labs Limited is a pharmaceutical products and services provider. The Company is primarily engaged in formulation and manufacturing lyophilized products.

Financial TrendFinancial statements 

201920202021202272.8766.3387.81196.17-5.56-60.54-11.5539.00
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Copy of Newspaper Publication 
Announced OnJan 25, 2023

Lyka Labs Limited has informed the Exchange about Copy of Newspaper Publication | Download

Lyka Labs Limited has informed the Exchange about Copy of Newspaper Publication | Download

Updates 
Announced OnJan 25, 2023

Lyka Labs Limited has informed the Exchange regarding ''. | Download

Lyka Labs Limited has informed the Exchange regarding ''. | Download

Loss of Share Certificates 
Announced OnJan 25, 2023

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; the Company has given effect to the issuance of duplicate share certificate in lieu of lost / misplaced share certificate: | Download

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; the Company has given effect to the issuance of duplicate share certificate in lieu of lost / misplaced share certificate: | Download

See all events